Regional reports and positions

With the aim of promoting equal pay for women and men, the Brazilian Government has recently enforced a law requiring all companies with more than 100 employees to share a report displaying data (compiled by the Brazilian Government) on remuneration between the genders.

As a company we believe in offering equal opportunities and ensuring that both women and men have the same rights, responsibilities, and opportunities for advancement based on merit. We are committed to ensure equal pay for equal work, and we will continue to champion diversity and inclusivity in all aspects of our operations. We welcome all initiatives that promote equality and diversity. The data is compiled by the Brazilian Government.
 

September 2025:

Download the report for legacy Chr. Hansen - PT

Download the report for legacy Novozymes - PT

March 2025:

Download the report for legacy Chr. Hansen - PT
Download the context to the legacy Chr. Hansen report - PT

Download the report for legacy Novozymes - PT
Download the context to the legacy Novozymes report - PT
For the English version of the context to the legacy Novozymes report, click here.

September 2024:

Download the report for legacy Chr. Hansen - PT
Download the context to the legacy Chr. Hansen report - PT

Download the report for legacy Novozymes - PT
Download the context to the legacy Novozymes report - PT
For the English version of the context to the legacy Novozymes report, click here.
 

March 2024:

Download the report for legacy Chr. Hansen - PT
Download the context to the legacy Chr. Hansen report - PT

Download the report for legacy Novozymes - PT
Download the context to the legacy Novozymes report - PT
For the English version of the context to the legacy Novozymes report, click here.
 

As of December 31, 2025, the Board of Directors comprised 12 members. Eight were elected by shareholders: three women (38%) and five men, and four were elected by employees in Denmark: one woman (25%) and three men. According to the methodology of the Gender Balance Act, gender balance was achieved in both groups.

Executive Management comprised two members, the CEO and the CFO, with one woman (50%) and one man (50%). The Executive Leadership Team (ExLT), which includes the Executive Management, consisted of two women (25%) and six men (75%). In 2025, the Board set a target of 30% female representation for “other management levels” at Novozymes A/S by June 30, 2026. “Other management levels” covers the ExLT and people managers reporting to them. To support this target, Novonesis has advanced inclusive hiring practices, reinforced shared leadership accountability for promotions, and addressed structural barriers such as flexibility, organizational design, and visible role models. As of December 31, 2025, the number of employees at other management levels was 42, of which 29 % were female.

In this document, you will find the tax strategy for Novonesis subsidiaries in the U.K. Publicizing this document is a requirement in the U.K. To access the tax policy of the Novonesis group please refer to Novonesis - Policies & Positions

Novonesis Tax Strategy in the United Kingdom
This document sets out Novonesis’ strategy and approach to conducting its tax affairs in the U.K.
This strategy applies to the list of entities set out below. The strategy is in effect for the current financial year and reviewed annually. Novonesis regards the publication of this tax strategy as complying with the duty under paragraph 16(2) of Schedule 19 of the Finance Act 2016.

Risk management and governance arrangements
The Novonesis tax policy sets out the group’s approach to conducting its tax affairs. The policy applies to all of Novonesis’ group entities, including those in the U.K. Please refer to the risk management and governance descriptions in the Novonesis tax policy.
The tax team in the corporate headquarter and the finance employees responsible for U.K. affiliates are in regular dialogue. This dialogue ensures that issues that may have a material tax impact are addressed and items that create tax risk are effectively managed.

Attitude towards tax planning and level of risk
The Novonesis tax policy sets out the group’s approach to tax planning and level of risk. The policy applies to all of Novonesis’ group entities, including those in the U.K. Please refer to the Novonesis tax policy.
Relationship with HMRC
In accordance with the Novonesis tax policy, the group seeks good relationships with all tax authorities, including HMRC.
We are committed to the principles of openness and transparency in our approach to dealing with tax authorities wherever we operate around the world. All dealings with the tax authorities and with other relevant bodies will be conducted in a collaborative, courteous and timely manner.

List of entities covered by this Tax Strategy
• Novozymes U.K. Ltd.
• Chr. Hansen (UK) Limited

Here you will find the tax strategy for Polish subsidiaries in the Novonesis group. Publicizing these documents is a requirement in Poland.

Tax Strategy Report for 2023/2024 (in Polish)
Download the report / Pobierz raport

Tax Strategy Report for 2022/2023 (in Polish)
Download the report / Pobierz raport

To access the Tax Policy of the Novonesis group, please click here:

Novonesis joint statement on Modern slavery